• Mashup Score: 3

    LINC 23 – We are joined by Principal Investigator, Dr Sahil Parikh (Columbia University Irving Medical Center, US) to discuss Abbott’s LIFE-BTK Randomised Controlled Trial. The

    Tweet Tweets with this article
    • #TCT2023 #LBT study highlights:#LifeBTK Nice video summarizing study design: https://t.co/jNbT1qz8t2 @sbrugaletta do you remember the #BVS concept? it has been redesigned and was investigated in #BTK. Do not miss the results at @TCTConference by @sahilparikhmd… https://t.co/6Z21dURm8w

  • Mashup Score: 1
    article - 7 month(s) ago

    IntroductionChronic lymphocytic leukemia (CLL) is the most common type of leukemia affecting adults in western countries, mainly affecting older adults, with a median age at diagnosis of 72 years;1,2 its incidence and prevalence are expected to further increase in the short-term, proportionally increasing with the aging of the population.Chemo-immunotherapy regimens (eg, fludarabine…

    Tweet Tweets with this article
    • Chemo-immunotherapy regimens have been the standard of care for #ChronicLymphocyticLeukemia. Yet, novel targeted agents—like #BTK and B-cell lymphoma-2 inhibitors—offer therapeutic options with higher #efficacy and personalized treatment. Learn more: https://t.co/BOKL4lNyrg #CLL https://t.co/2eC26XEqnd

  • Mashup Score: 0

    Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the…

    Tweet Tweets with this article
    • Register now to hear the advances in understanding of the immune mechanisms that contribute to the pathophysiology of multiple sclerosis. https://t.co/aAkONDm5ra #gotoper #BTK #MS https://t.co/TCBN2Q2oCR